蚌埠医学院学报
蚌埠醫學院學報
방부의학원학보
ACTA ACADEMIAE MEDICINAE BENGBU
2014年
6期
760-761,764
,共3页
结肠肿瘤%肠梗阻%结肠切除术
結腸腫瘤%腸梗阻%結腸切除術
결장종류%장경조%결장절제술
colon neoplasms%intestinal obstruction%colectomy
目的:探讨一期切除吻合术治疗左半结肠癌合并急性肠梗阻临床疗效。方法:2008年2月至2011年2月对采用一期切除吻合术治疗的左半结肠癌合并急性肠梗阻27例进行回顾分析,作为观察组;选择同期接受传统二期吻合术治疗的患者19例作为对照组。比较2组患者术后排气时间、住院时间、术中出血量、并发症及3年生存率。结果:2组患者术后排气时间、住院时间、术中出血量及术后并发症发生率差异均无统计学意义(P>0.05)。观察组3年生存率为92.6%,对照组为63.2%,差异有统计学意义(P<0.05)。结论:一期切除吻合术治疗左半结肠癌合并急性肠梗阻安全可靠,且能够提高远期生存率,值得临床推广。
目的:探討一期切除吻閤術治療左半結腸癌閤併急性腸梗阻臨床療效。方法:2008年2月至2011年2月對採用一期切除吻閤術治療的左半結腸癌閤併急性腸梗阻27例進行迴顧分析,作為觀察組;選擇同期接受傳統二期吻閤術治療的患者19例作為對照組。比較2組患者術後排氣時間、住院時間、術中齣血量、併髮癥及3年生存率。結果:2組患者術後排氣時間、住院時間、術中齣血量及術後併髮癥髮生率差異均無統計學意義(P>0.05)。觀察組3年生存率為92.6%,對照組為63.2%,差異有統計學意義(P<0.05)。結論:一期切除吻閤術治療左半結腸癌閤併急性腸梗阻安全可靠,且能夠提高遠期生存率,值得臨床推廣。
목적:탐토일기절제문합술치료좌반결장암합병급성장경조림상료효。방법:2008년2월지2011년2월대채용일기절제문합술치료적좌반결장암합병급성장경조27례진행회고분석,작위관찰조;선택동기접수전통이기문합술치료적환자19례작위대조조。비교2조환자술후배기시간、주원시간、술중출혈량、병발증급3년생존솔。결과:2조환자술후배기시간、주원시간、술중출혈량급술후병발증발생솔차이균무통계학의의(P>0.05)。관찰조3년생존솔위92.6%,대조조위63.2%,차이유통계학의의(P<0.05)。결론:일기절제문합술치료좌반결장암합병급성장경조안전가고,차능구제고원기생존솔,치득림상추엄。
Objective:To investigate the clinical effects of the one-stage resection and anastomosis in the treatment of left colon carcinoma complicated with acute obstruction. Methods:The left colon carcinoma complicated with acute obstruction patients treated with one-staged resection and anastomosis and traditional two-stage anastomosis were divided into the observation group(27 cases) and control group(19 cases),respectively. The postoperative exhaust time,intraoperative blood loss,hospital stay,complications and 3-year survival rate between two groups were compared. Results:The differences of the postoperative exhaust time,intraoperative blood loss, hospital stay and complications between two groups were not statistically signifficant(P>0. 05). The 3-year survival rates of observation group and control group were 92. 5% and 63. 2%,respectively,the difference of which was statistically significant(P <0. 05). Conclusions:The one-stage resection and anastomosis in the treatment of left colon carcinoma complicated with acute obstruction is safe and reliable,which can improve the long-term survival rate,and is worth clinical promotion.